Transitioning from clozapine to Cobenfy (xanomeline-trospium chloride) in treatment resistant schizophrenia and clozapine induced OCD

Authors

Institutions

Publication Details

Journal
BMC Psychiatry
Published
2026-05-02
DOI
https://doi.org/10.1186/s12888-026-07795-7
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transitioning from clozapine to Cobenfy (xanomeline-trospium chloride) in treatment resistant schizophrenia and clozapine induced OCD

Ali Nakip, Stephen F. Lewis, Rachel M Rose
BMC Psychiatry
Schizophrenia research and treatment
article

Transitioning from clozapine to Cobenfy (xanomeline-trospium chloride) in treatment resistant schizophrenia and clozapine induced OCD

Ali Nakip, Stephen F. Lewis, Rachel M Rose
article en

Abstract

No abstract available for this paper.
BMC Psychiatry
University of New Mexico (US)
Good health and well-being
Openalex Percentile: Top 10%
Schizophrenia research and treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.